Insider · CIK 0001789507
David E. Wheadon
director
Files at VXRT (Vaxart, Inc.), INDV (Indivior Pharmaceuticals, Inc.), SHC (Sotera Health Co). First filing Jan 7, 2026, latest Jan 7, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$63k bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | Indivior Pharmaceuticals, Inc. | $63k 1,771 shares | +14% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | INDV Indivior Pharmaceuticals, Inc. | AGrant or award Common Stock | +5,955 | $0.00 | $0 | 20,350 | Jan 28, 2026 |
| Jan 5, 2026 | INDV Indivior Pharmaceuticals, Inc. | POpen-market purchase Ordinary Shares10b5-1 | +1,771 | $35.39 | $63k | 14,395 | Jan 7, 2026 |
| Jun 13, 2025 | VXRT Vaxart, Inc. | AGrant or award Common Stock | +16,000 | $0.00 | $0 | 46,750 | Jun 16, 2025 |
| Jun 13, 2025 | VXRT Vaxart, Inc. | AGrant or award Stock Option (right to buy)derivative | +95,400 | $0.00 | $0 | 95,400 | Jun 16, 2025 |
| May 22, 2025 | SHC Sotera Health Co | AGrant or award Common Stock, $0.01 par value per share ("Common Stock") | +19,132 | $0.00 | $0 | 74,912 | May 27, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.